Revenue
2024
2025
2026
MiniMed Group, Inc. (MMED)
Price—Loading quote
Net income
2024
2025
2026
Free cash flow
2024
2025
2026
Total cash / debt
CashTotal debt
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Gross profit | $1.68B | $1.53B | $1.44B |
| Research & development | $448.0M | $436.0M | $437.0M |
| Operating income | −$190.0M | −$146.0M | −$69.0M |
| EBITDAderived | −$34.0M | −$3.0M | $60.0M |
| Net income | −$333.0M | −$213.0M | −$112.0M |
| Basic EPSper diluted share | -$1.30 | -$0.84 | -$0.44 |
| Diluted EPSper diluted share | -$1.30 | -$0.84 | -$0.44 |